SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-013555
Filing Date
2024-03-28
Accepted
2024-03-28 12:18:57
Documents
1
Period of Report
2024-03-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1711642726.html 4  
1 FORM 4 wk-form4_1711642726.xml 4 3304
  Complete submission text file 0001628280-24-013555.txt   4751
Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Issuer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address
Lee Sung (Reporting) CIK: 0001793200 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39083 | Film No.: 24796320